| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/11/2007 | CN1943660A A Chinese traditional medicinal composition for treatment of constipation and its preparation method |
| 04/11/2007 | CN1943658A A Chinese traditional medicinal composition for treating acute, chronic hepatitis and preparing method |
| 04/11/2007 | CN1943657A A Chinese traditional medicinal composition and its preparation method |
| 04/11/2007 | CN1943654A A Chinese traditional medicinal composition and its preparation method |
| 04/11/2007 | CN1943647A The method for preparing triterpenic acid extract from the loquat leaves |
| 04/11/2007 | CN1943646A The recipe of peptide protein for treating hepatocirrhosis ascites and big and small three Yang caused by hepatitis B virus |
| 04/11/2007 | CN1943634A Consumptive Cattle and fattening composition and its feeding method |
| 04/11/2007 | CN1943631A A Chinese traditional medicinal composition for treating toothache and dental arthritis and its preparing method |
| 04/11/2007 | CN1943626A Dispersion tablet for protecting liver and promoting bile and its preparing method |
| 04/11/2007 | CN1943625A Oral sterilizing liquid |
| 04/11/2007 | CN1943623A Medicine for treating hepatitis B |
| 04/11/2007 | CN1943619A Method for preparing Chinese medicine origanum volatile oil and its soft capsule |
| 04/11/2007 | CN1943607A Chinese medicine composition and its preparing method |
| 04/11/2007 | CN1943605A Process for preparing hypericum japonicum extract |
| 04/11/2007 | CN1943602A Bee pollen bee glue composition and its preparing method |
| 04/11/2007 | CN1943600A Medicinal composition containing American cockroach and its ethanol extract and new use |
| 04/11/2007 | CN1943582A Foscarnet sodium composition |
| 04/11/2007 | CN1943579A Use of asiatic acid in preparing medicine |
| 04/11/2007 | CN1943574A Method for preparing tinidazole dispersion tablet and use |
| 04/11/2007 | CN1943568A Rumen protection amino acid and preparing method |
| 04/11/2007 | CN1310029C Method for controlling quality of liangfuwan |
| 04/11/2007 | CN1309839C Triterpenoid saponin compound extracting process and orally taken product therewith |
| 04/11/2007 | CN1309830C Variants of TRAF2 which act as an inhibitor of TNF-alpha signaling pathway |
| 04/11/2007 | CN1309734C Polypeptides involved in immune response |
| 04/11/2007 | CN1309717C 4-aryl group-5H-thoifuran-2-ketone derivative, producing method and use thereof |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309425C Method of treating canker sores with patches to speed healing and relieve pain |
| 04/11/2007 | CN1309420C Anticarious preparation of antibody |
| 04/11/2007 | CN1309419C A Blocking monoclonal antibody to VLA-1 and its use |
| 04/11/2007 | CN1309411C Fat-eliminating liver-protecting medicine capsule for treating hepatosis and its preparation method |
| 04/11/2007 | CN1309410C Chinese medicine for treating stomach disease |
| 04/11/2007 | CN1309407C Recipe and prodn. method of medicine for pancrease-prevention and keeping in good health |
| 04/11/2007 | CN1309402C Chinese drug for treating cholecystitis |
| 04/11/2007 | CN1309388C Treatment of inflammatory disorders |
| 04/11/2007 | CN1309384C 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity |
| 04/11/2007 | CN1309383C Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/11/2007 | CN1309372C Preparation of granular powder for treating hepatitis and quality control method |
| 04/11/2007 | CN1309371C Granular preparation for treating deficiency of vital energy and anaemia and its quality control method |
| 04/11/2007 | CN1309367C Preparation of Chinese traditional medicine for curing gallstone and preparation method thereof |
| 04/11/2007 | CN1309316C Vital cell preparations containing lactic acid bacterium as the ative ingredient and food containing lactic acid |
| 04/11/2007 | CN1309310C Method for increasing pet activity |
| 04/10/2007 | US7202381 Compounds as opioid receptor modulators |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202347 used to diagnose and/or treat a wide variety of liver and other disorders (cancer) and tracing hepatocyte lineage; genetic engineering |
| 04/10/2007 | US7202280 Methods for the treatment and prevention of pancreatitis and for induction of liver regeneration |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202277 Benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202268 1-Substituted with an alkylthioalkyl-, alkylsulfonylalkyl- or alkylaminosulfonylalkyl- group, e.g., 7-chloro-2-methyl-1-{3-[(methylsulfonyl)amino]-propyl}-N-[(1S)-endo-(1,3,3-trimethylbicyclo-[2.2.1]hept-2-yl)-1H-indole-3-carboxamide; cannabinoid CB2 receptor agonists |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/10/2007 | US7202235 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for controlling Cryptosporidium parvum disorders such as diarrhea, particularly in immunodeficient individuals |
| 04/10/2007 | US7202224 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/10/2007 | US7202066 Synergistic healing the wounds |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2379197C New sulfonyl derivatives of .alpha.-amino acids, process for their preparation and pharmaceutical compositions containing them |
| 04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 04/10/2007 | CA2171289C Il8 inhibitors |
| 04/10/2007 | CA2153937C Tricyclic pyrazole derivatives |
| 04/07/2007 | CA2562767A1 Implantable pump for protein delivery for obesity control by drug infusion into the brain |
| 04/05/2007 | WO2007037746A1 Use of a composition comprising an antacid, a mucolytic an a gelling agent in the treatment of cold. |
| 04/05/2007 | WO2007037743A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 04/05/2007 | WO2007037742A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037514A1 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 04/05/2007 | WO2007037492A1 Therapeutic agent for periodontal disease containing extracted ingredient from plat belonging to family salicaceae, genus salix |
| 04/05/2007 | WO2007036363A2 Compositions containing butyric acid ester of carbohydrates and carbohydrate polyols |
| 04/05/2007 | WO2007021575A3 Acetylenic piperazines as metabotropic glutamate receptor antagonists |
| 04/05/2007 | WO2006111830A3 Functional aphrodisiac rolled herbal bidis and cigarettes |
| 04/05/2007 | US20070079389 Method for screening PTPzeta activity promoter or inhibitor |
| 04/05/2007 | US20070078153 4-Oxoimidazolidine-2-spiropiperidine derivatives |
| 04/05/2007 | US20070078104 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; antiinflammatory agents |
| 04/05/2007 | US20070078080 N4-Acylcytosine Nucleosides for Treatment of Viral Infections |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | CA2624491A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia |
| 04/04/2007 | EP1770065A1 Sodium hydrogencarbonate crystal grains with low level of integrity and process for producing the same |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1768674A1 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| 04/04/2007 | EP1768664A1 Combination of dpp-iv inhibitors and compounds modulating 5-ht3 and/or 5-ht4 receptors |
| 04/04/2007 | EP1663206B1 1-(2,3-dimethyl-phenyl)-ethyl-1,3-dihydro-imidazole-2-thione as non-sedating alpha 2a agonist |
| 04/04/2007 | EP1541673B1 Probiotics for pet food applications |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | EP1532135B1 Nf-kb inhibitors |
| 04/04/2007 | EP1465890B1 Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1401422B1 Halogenated composition, method for preparing same and uses thereof |
| 04/04/2007 | EP1259595B1 Integrin antagonists |
| 04/04/2007 | EP1219609B1 Aromatic nitrogenous six-membered ring compounds |
| 04/04/2007 | CN1942196A Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease |